• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管风险和慢性阻塞性肺疾病的替代标志物:一项大型病例对照研究。

Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study.

机构信息

From the Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, United Kingdom (M.F., C.M.M., K.M.-P., J.W.-S., J.C., I.B.W.); School of Healthcare Sciences (N.G.) and Department of Cardiology, Wales Heart Research Institute (M.M., J.R.C.), Cardiff University, United Kingdom; Cambridge Clinical Trials Unit (J.R.F., J.C., I.B.W.) and Division of Respiratory Medicine (J.F.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom; GSK R&D, King of Prussia, PA (D.M., R.T.S.); and NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United Kingdom (D.M., M.I.P.).

出版信息

Hypertension. 2018 Mar;71(3):499-506. doi: 10.1161/HYPERTENSIONAHA.117.10151. Epub 2018 Jan 22.

DOI:10.1161/HYPERTENSIONAHA.117.10151
PMID:29358458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5805278/
Abstract

Cardiovascular disease is a common comorbidity and cause of mortality in chronic obstructive pulmonary disease. A better understanding of mechanisms of cardiovascular risk in chronic obstructive pulmonary disease patients is needed to improve clinical outcomes. We hypothesized that such patients have increased arterial stiffness, wave reflections, and subclinical atherosclerosis compared with controls and that these findings would be independent of smoking status and other confounding factors. A total of 458 patients with a diagnosis of chronic obstructive pulmonary disease and 1657 controls (43% were current or ex-smokers) with no airflow limitation were matched for age, sex, and body mass index. All individuals underwent assessments of carotid-femoral (aortic) pulse wave velocity, augmentation index, and carotid intima-media thickness. The mean age of the cohort was 67±8 years and 58% were men. Patients with chronic obstructive pulmonary disease had increased aortic pulse wave velocity (9.95±2.54 versus 9.27±2.41 m/s; <0.001), augmentation index (28±10% versus 25±10%; <0.001), and carotid intima-media thickness (0.83±0.19 versus 0.74±0.14 mm; <0.001) compared with controls. Chronic obstructive pulmonary disease was associated with increased levels of each vascular biomarker independently of physiological confounders, smoking, and other cardiovascular risk factors. In this large case-controlled study, chronic obstructive pulmonary disease was associated with increased arterial stiffness, wave reflections, and subclinical atherosclerosis, independently of traditional cardiovascular risk factors. These findings suggest that the cardiovascular burden observed in this condition may be mediated through these mechanisms and supports the concept that chronic obstructive pulmonary disease is an independent risk factor for cardiovascular disease.

摘要

心血管疾病是慢性阻塞性肺疾病的常见合并症和死亡原因。为了改善临床结局,我们需要更好地了解慢性阻塞性肺疾病患者心血管风险的机制。我们假设,与对照组相比,这些患者的动脉僵硬度、波反射和亚临床动脉粥样硬化增加,并且这些发现与吸烟状况和其他混杂因素无关。共有 458 例慢性阻塞性肺疾病患者和 1657 例无气流限制的对照组(43%为现吸烟者或曾吸烟者)与年龄、性别和体重指数相匹配。所有个体均接受了颈动脉-股动脉(主动脉)脉搏波速度、增强指数和颈动脉内膜中层厚度的评估。队列的平均年龄为 67±8 岁,58%为男性。与对照组相比,慢性阻塞性肺疾病患者的主动脉脉搏波速度(9.95±2.54 对 9.27±2.41 m/s;<0.001)、增强指数(28±10%对 25±10%;<0.001)和颈动脉内膜中层厚度(0.83±0.19 对 0.74±0.14 mm;<0.001)更高。慢性阻塞性肺疾病与每个血管生物标志物的水平升高独立于生理混杂因素、吸烟和其他心血管危险因素相关。在这项大型病例对照研究中,慢性阻塞性肺疾病与动脉僵硬度、波反射和亚临床动脉粥样硬化的增加独立相关,而与传统心血管危险因素无关。这些发现表明,在这种情况下观察到的心血管负担可能通过这些机制介导,并支持慢性阻塞性肺疾病是心血管疾病的独立危险因素的概念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/5805278/94daf351e972/hyp-71-499-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/5805278/94daf351e972/hyp-71-499-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46e9/5805278/94daf351e972/hyp-71-499-g004.jpg

相似文献

1
Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study.心血管风险和慢性阻塞性肺疾病的替代标志物:一项大型病例对照研究。
Hypertension. 2018 Mar;71(3):499-506. doi: 10.1161/HYPERTENSIONAHA.117.10151. Epub 2018 Jan 22.
2
Aortic arterial stiffness associates with carotid intima-media thickness and carotid plaques in younger middle-aged healthy people.年轻中年健康人群中,主动脉动脉僵硬度与颈动脉内膜中层厚度和颈动脉斑块相关。
Blood Press. 2024 Dec;33(1):2405161. doi: 10.1080/08037051.2024.2405161. Epub 2024 Sep 18.
3
Aerobic exercise training does not alter vascular structure and function in chronic obstructive pulmonary disease.有氧运动训练不会改变慢性阻塞性肺疾病患者的血管结构和功能。
Exp Physiol. 2017 Nov 1;102(11):1548-1560. doi: 10.1113/EP086379. Epub 2017 Sep 30.
4
[Relationship of arterial wall parameters to cardiovascular risk factors and cardiovascular risk assessed by SCORE system].[动脉壁参数与心血管危险因素及通过SCORE系统评估的心血管风险之间的关系]
Medicina (Kaunas). 2007;43(7):529-41.
5
Airflow limitation in smokers is associated with subclinical atherosclerosis.吸烟者的气流受限与亚临床动脉粥样硬化有关。
Am J Respir Crit Care Med. 2009 Jan 1;179(1):35-40. doi: 10.1164/rccm.200804-560OC. Epub 2008 Oct 17.
6
Subclinical atherosclerosis risk markers in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.慢性阻塞性肺疾病患者的亚临床动脉粥样硬化风险标志物:一项系统评价和荟萃分析。
Respir Med. 2017 Feb;123:18-27. doi: 10.1016/j.rmed.2016.12.004. Epub 2016 Dec 8.
7
Radial augmentation index is a surrogate marker of atherosclerotic burden in a primary prevention cohort.桡动脉增强指数是初级预防队列中动脉粥样硬化负担的替代标志物。
Atherosclerosis. 2013 Dec;231(2):436-41. doi: 10.1016/j.atherosclerosis.2013.10.004. Epub 2013 Oct 12.
8
Carotid arterial stiffness in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的颈动脉僵硬度
Acta Physiol Hung. 2011 Jun;98(2):117-27. doi: 10.1556/APhysiol.98.2011.2.3.
9
Subclinical Atherosclerosis Is Not Accelerated in Patients with Ankylosing Spondylitis with Low Disease Activity: New Data and Metaanalysis of Published Studies.疾病活动度低的强直性脊柱炎患者亚临床动脉粥样硬化并未加速:新数据及已发表研究的荟萃分析
J Rheumatol. 2015 Nov;42(11):2098-105. doi: 10.3899/jrheum.150316. Epub 2015 Oct 1.
10
The association between chronic hepatitis C infection and cardiovascular risk.慢性丙型肝炎感染与心血管风险之间的关联。
Intern Med J. 2016 Jan;46(1):63-70. doi: 10.1111/imj.12936.

引用本文的文献

1
Biological pathways and mechanisms linking COPD and cardiovascular disease.连接慢性阻塞性肺疾病(COPD)与心血管疾病的生物学途径和机制。
Ther Adv Chronic Dis. 2025 Mar 28;16:20406223251314286. doi: 10.1177/20406223251314286. eCollection 2025.
2
Dysregulation of lipid mediators in patients with frequent exacerbations of COPD.慢性阻塞性肺疾病频繁急性加重患者脂质介质的失调
ERJ Open Res. 2025 Mar 24;11(2). doi: 10.1183/23120541.00950-2023. eCollection 2025 Mar.
3
Effectiveness of high-intensity inspiratory muscle training, and resistance and aerobic exercise for cardiovascular health in chronic obstructive pulmonary disease (HIRAC-COPD): a randomized controlled trial protocol.

本文引用的文献

1
A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.一项关于每日一次糠酸氟替卡松/维兰特罗或维兰特罗与安慰剂对比的随机试验,以确定对慢性阻塞性肺疾病患者动脉僵硬度的影响。
Int J Chron Obstruct Pulmon Dis. 2017 Jan 19;12:351-365. doi: 10.2147/COPD.S117373. eCollection 2017.
2
Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study.外周动脉疾病及其在 COPD 和系统后果-合并症网络研究中的慢性阻塞性肺疾病患者中的临床相关性。
Am J Respir Crit Care Med. 2017 Jan 15;195(2):189-197. doi: 10.1164/rccm.201602-0354OC.
3
高强度吸气肌训练、阻力训练及有氧运动对慢性阻塞性肺疾病心血管健康的影响(HIRAC-COPD):一项随机对照试验方案
BMC Pulm Med. 2024 Dec 20;24(1):627. doi: 10.1186/s12890-024-03385-z.
4
The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis.吸烟在慢性阻塞性肺疾病和动脉粥样硬化发病机制中的作用。
Int J Mol Sci. 2023 May 13;24(10):8725. doi: 10.3390/ijms24108725.
5
Effectiveness and Safety of Multicomponent Physical Training in Patients With Chronic Obstructive Pulmonary Disease: Protocol for a Randomized Clinical Trial.多组分体育锻炼对慢性阻塞性肺疾病患者的有效性和安全性:一项随机临床试验方案
Health Serv Insights. 2023 May 2;16:11786329231169255. doi: 10.1177/11786329231169255. eCollection 2023.
6
Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study.肺量计确诊慢性阻塞性肺疾病对经皮冠状动脉介入治疗后动脉僵硬度和表面活性蛋白 D 的影响。CATEPOC 研究。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 14;17:2577-2587. doi: 10.2147/COPD.S373853. eCollection 2022.
7
Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics.慢性阻塞性肺疾病与动脉粥样硬化:共同的发病机制与治疗新策略。
Clin Sci (Lond). 2022 Mar 31;136(6):405-423. doi: 10.1042/CS20210835.
8
Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease.肺和冠状动脉疾病中的常见生理和蛋白质组学生物标志物。
PLoS One. 2022 Mar 9;17(3):e0264376. doi: 10.1371/journal.pone.0264376. eCollection 2022.
9
Left ventricular diastolic dysfunction in non-severe chronic obstructive pulmonary disease - a step forward in cardiovascular comorbidome.非重度慢性阻塞性肺疾病患者的左心室舒张功能障碍——心血管共病领域的新进展。
PLoS One. 2021 Mar 8;16(3):e0247940. doi: 10.1371/journal.pone.0247940. eCollection 2021.
10
The Role of Stress Echocardiography in the Early Detection of Diastolic Dysfunction in Non-Severe Chronic Obstructive Pulmonary Disease Patients.负荷超声心动图在非重度慢性阻塞性肺疾病患者舒张功能障碍早期检测中的作用
Arq Bras Cardiol. 2021 Feb;116(2):259-265. doi: 10.36660/abc.20190623.
Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
慢性阻塞性肺疾病患者心血管合并症的风险:系统评价和荟萃分析。
Lancet Respir Med. 2015 Aug;3(8):631-9. doi: 10.1016/S2213-2600(15)00241-6. Epub 2015 Jul 22.
4
Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease.肺功能、亚临床动脉粥样硬化和冠状动脉疾病风险的常见遗传决定因素。
PLoS One. 2014 Aug 5;9(8):e104082. doi: 10.1371/journal.pone.0104082. eCollection 2014.
5
Evaluating the role of inflammation in chronic airways disease: the ERICA study.评估炎症在慢性气道疾病中的作用:ERICA研究。
COPD. 2014 Sep;11(5):552-9. doi: 10.3109/15412555.2014.898031. Epub 2014 May 15.
6
Arterial stiffness in COPD.COPD 中的动脉僵硬度。
Chest. 2014 Apr;145(4):861-875. doi: 10.1378/chest.13-1809.
7
Common carotid intima-media thickness measurements do not improve cardiovascular risk prediction in individuals with elevated blood pressure: the USE-IMT collaboration.常见颈动脉内膜中层厚度测量并不能改善血压升高个体的心血管风险预测:USE-IMT 协作研究。
Hypertension. 2014 Jun;63(6):1173-81. doi: 10.1161/HYPERTENSIONAHA.113.02683. Epub 2014 Mar 10.
8
Chronic obstructive pulmonary disease and comorbidities.慢性阻塞性肺疾病及其合并症。
Lancet Respir Med. 2013 Mar;1(1):73-83. doi: 10.1016/S2213-2600(12)70060-7. Epub 2013 Jan 14.
9
Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects.主动脉脉搏波速度可改善心血管事件预测:来自 17635 名受试者的前瞻性观察性数据的个体参与者荟萃分析。
J Am Coll Cardiol. 2014 Feb 25;63(7):636-646. doi: 10.1016/j.jacc.2013.09.063. Epub 2013 Nov 13.
10
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.2013年欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理实践指南:ESH/ESC动脉高血压管理特别工作组
J Hypertens. 2013 Oct;31(10):1925-38. doi: 10.1097/HJH.0b013e328364ca4c.